Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study
{{output}}
Aims: The HEYMANS study observed patients receiving evolocumab as part of routine clinical hyperlipidemia management. It was designed to capture data on clinical parameters relevant to health authorities and physicians. ... ...
